Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation.
Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation.
复制标题
DOI:
10.1055/s-0040-1709127
复制
发表时间:
2021-08
影响因子:
2
通讯作者:
Ambrose CS
中科院分区:
文献类型:
--
作者:
Goldstein M;Krilov LR;Fergie J;Brannman L;Wade SW;Kong AM;Ambrose CS
Objective The aim of this study is to compare outpatient respiratory syncytial virus (RSV) immunoprophylaxis (IP) use and relative RSV hospitalization (RSVH) rates for infants <29 weeks' gestational age (wGA) versus term infants before and after the 2014 American Academy of Pediatrics (AAP) policy change. Study Design Infants were identified in the MarketScan Commercial and Multi-State Medicaid databases. Outpatient RSV IP receipt and relative <29 wGA/term hospitalization risks in 2012 to 2014 and 2014 to 2016 were assessed using rate ratios and a difference-in-difference model. Results Outpatient RSV IP receipt by infants <29 wGA and aged <3 months in the Commercial and Medicaid populations and those aged 3 to <6 months in the Medicaid population declined after 2014. Relative RSVH risks for infants <29 wGA were numerically greater after 2014, with infants aged <3 months and Medicaid infants experiencing the greatest increases. Difference-in-difference results indicated a significantly increased relative risk of RSVH for infants <29 wGA versus term (both cohorts aged 0 to <6 months) in the Medicaid-insured population (1.68, p = 0.0054). A nonsignificant increase of similar magnitude occurred in the commercially insured population (1.57, p = 0.2867). Conclusion The 2014 policy change was associated with a decrease in RSV IP use and an increase in RSVH risk among otherwise healthy infants <29 wGA.
登录
查看更多内容
影响因子:
3.6
作者:
Bardach NS;Cabana MD
通讯作者:
Cabana MD
DOI:
10.1056/nejmoa0804877
发表时间:
2009-02-05
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hall CB;Weinberg GA;Iwane MK;Blumkin AK;Edwards KM;Staat MA;Auinger P;Griffin MR;Poehling KA;Erdman D;Grijalva CG;Zhu Y;Szilagyi P
通讯作者:
Szilagyi P
影响因子:
2
作者:
Ambrose, Christopher S.
通讯作者:
Ambrose, Christopher S.
影响因子:
8
作者:
Ralston, Shawn L.;Lieberthal, Allan S.;Hernandez-Cancio, Sinsi
通讯作者:
Hernandez-Cancio, Sinsi
影响因子:
1.6
作者:
Makari D;Staat MA;Henrickson KJ;Wu X;Ambrose CS
通讯作者:
Ambrose CS